Dr Alexander R Bottini, MD | |
1255 Friendship Rd Ste 160, Braselton, GA 30517-5618 | |
(678) 528-1101 | |
(678) 528-3254 |
Full Name | Dr Alexander R Bottini |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 9 Years |
Location | 1255 Friendship Rd Ste 160, Braselton, Georgia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033505086 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Northeast Georgia Medical Center, Inc | Gainesville, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Georgia Retina, Pc | 1254328248 | 20 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that Genentech, a member of the Roche Group, has disclosed that the U.S. Food and Drug Administration (FDA) has officially accepted the Biologics License Application (BLA) for trastuzumab emtansine and granted it Priority Review.
In a breakthrough study, scientists at the Rockefeller University have observed the effects of Huntington's disease in neurons as early as conception.
Natural health experts BetterYou have welcomed a recommendation by leading gastroenterology expert Isobel Mason, to take a vitamin D supplement to reduce Crohn's flare-ups.
Cytomedix, Inc., a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced the closing of an agreement with Sorin Group, a global leader in the treatment of cardiovascular diseases, to acquire the Angel® Whole Blood Separation System and activAT® Autologous Thrombin Processing Kit for $7 million in cash, to be paid in installments over the next two and one-half years.
› Verified 5 days ago
Entity Name | Southeast Eye Surgery Center Pc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1629120928 PECOS PAC ID: 0345148979 Enrollment ID: O20031222000062 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that Genentech, a member of the Roche Group, has disclosed that the U.S. Food and Drug Administration (FDA) has officially accepted the Biologics License Application (BLA) for trastuzumab emtansine and granted it Priority Review.
In a breakthrough study, scientists at the Rockefeller University have observed the effects of Huntington's disease in neurons as early as conception.
Natural health experts BetterYou have welcomed a recommendation by leading gastroenterology expert Isobel Mason, to take a vitamin D supplement to reduce Crohn's flare-ups.
Cytomedix, Inc., a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced the closing of an agreement with Sorin Group, a global leader in the treatment of cardiovascular diseases, to acquire the Angel® Whole Blood Separation System and activAT® Autologous Thrombin Processing Kit for $7 million in cash, to be paid in installments over the next two and one-half years.
› Verified 5 days ago
Entity Name | Georgia Retina, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023027430 PECOS PAC ID: 1254328248 Enrollment ID: O20040430000133 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that Genentech, a member of the Roche Group, has disclosed that the U.S. Food and Drug Administration (FDA) has officially accepted the Biologics License Application (BLA) for trastuzumab emtansine and granted it Priority Review.
In a breakthrough study, scientists at the Rockefeller University have observed the effects of Huntington's disease in neurons as early as conception.
Natural health experts BetterYou have welcomed a recommendation by leading gastroenterology expert Isobel Mason, to take a vitamin D supplement to reduce Crohn's flare-ups.
Cytomedix, Inc., a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced the closing of an agreement with Sorin Group, a global leader in the treatment of cardiovascular diseases, to acquire the Angel® Whole Blood Separation System and activAT® Autologous Thrombin Processing Kit for $7 million in cash, to be paid in installments over the next two and one-half years.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Alexander R Bottini, MD 1255 Friendship Rd Ste 160, Braselton, GA 30517-5618 Ph: (678) 528-1101 | Dr Alexander R Bottini, MD 1255 Friendship Rd Ste 160, Braselton, GA 30517-5618 Ph: (678) 528-1101 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that Genentech, a member of the Roche Group, has disclosed that the U.S. Food and Drug Administration (FDA) has officially accepted the Biologics License Application (BLA) for trastuzumab emtansine and granted it Priority Review.
In a breakthrough study, scientists at the Rockefeller University have observed the effects of Huntington's disease in neurons as early as conception.
Natural health experts BetterYou have welcomed a recommendation by leading gastroenterology expert Isobel Mason, to take a vitamin D supplement to reduce Crohn's flare-ups.
Cytomedix, Inc., a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced the closing of an agreement with Sorin Group, a global leader in the treatment of cardiovascular diseases, to acquire the Angel® Whole Blood Separation System and activAT® Autologous Thrombin Processing Kit for $7 million in cash, to be paid in installments over the next two and one-half years.
› Verified 5 days ago